Influence of Pranayama breathing techniques on thoracic cage biomechanics, respiratory muscle activity and lung function in patients with chronic respiratory disease: A randomized controlled trial
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 52
- 试验地点
- 2
- 主要终点
- •Kinematics of the thorax using 3D motion-capture system
研究概览
简要总结
The objective of the study is to evaluate the influence of Pranayama breathing techniques on thoracic cage biomechanics, respiratory muscle activity, and lung function in patients with chronic respiratory disease. It is a randomized controlled trial where two groups of patients with chronic respiratory disease will be undergoing rehabilitation for a period of 12 weeks. The control group will be receiving conventional pulmonary rehabilitation and the experimental group will receive additional Pranayam breathing techniques. The patients will be assessed for thoracic kinematic using reflective markers and the motion of the chest will be evaluated by the Vicon 3D motion capture system, respiratory muscle activity will be assessed by surface EMG, and pulmonary lung functions will measure the forced vital capacity, forced expiratory volume, at 1-second maximum inspiratory pressure, maximum expiratory and cardiovascular endurance will be recorded by six-minute walk test. The patient will be assessed at the beginning and end of the 12-week intervention. Knowledge gained from the study will help the prescription of evidence-based pulmonary rehabilitation including Pranayama to improve chest mobility, respiratory muscle activity, and lung function.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Open Label
入排标准
- 年龄范围
- 18.00 Year(s) 至 75.00 Year(s)（—）
- 性别
- All
入选标准
- •i.Any stable chronic respiratory diseases over 4 weeks (ICD 10 Classification- Bronchitis (J40-42), Emphysema (J43), other COPD (J44), Asthma (J45-46), Bronchiectasis (J47), Pneumoconiosis (J60-70), Adult respiratory distress syndrome (J80), Idiopathic Pulmonary Fibrosis (J84) ii.Age group of 18- 75 years both male and female iii.Mild to severe obstructions with GOLD grade 1-3, post bronchodilator FEV1/FVC <0.7, FEV1 30- 80% for obstructive conditions and FVC<80% with FEV1/FVC >0.7 for restrictive conditions.
排除标准
- •i.Recent exacerbation of the disease ii.Associated cardiac, psychological, neurological disorders iii.BMI >35 kg/m2 iv.Thoracic cage abnormalities like scoliosis, kyphosis, recent trauma, fractures of ribs.
结局指标
主要结局
•Kinematics of the thorax using 3D motion-capture system
时间窗: Pre intervention, at the 6th week of intervention, at the 12th week of intervention
•Assess the cardiovascular endurance using six-minute walk test
时间窗: Pre intervention, at the 6th week of intervention, at the 12th week of intervention
•Respiratory muscle activity assessment using surface EMG
时间窗: Pre intervention, at the 6th week of intervention, at the 12th week of intervention
•Pulmonary lung functions will measure the forced vital capacity, forced expiratory volume, at 1 second maximum inspiratory pressure, maximum expiratory
时间窗: Pre intervention, at the 6th week of intervention, at the 12th week of intervention
次要结局
未报告次要终点